Ole Munk

Mar 5, 2024 | ejnmmires.springeropen.com | Kim Vang |Anna Lyhne |Mette Pedersen |Ole Munk |André H. Dias |Anna Johnsson | +10 more

The protocol received approval from the Danish Medicines Agency (2019083844) and Central Denmark Region Committees on Health Research Ethics (1-10-72-195-19). The study is registered in the European Union Drug Regulating Authorities Clinical Trials Database (EudraCT: 2019-002665-35). The study was monitored by the Good Clinical Practice unit at Aarhus and Aalborg University Hospitals. Written and oral informed consent from all participating individuals were obtained.

Nov 30, 2023 | ejnmmires.springeropen.com | Paul Joseph Cumming |André H. Dias |Lars C. Gormsen |Allan K Hansen |Ian Alberts |Axel Rominger | +1 more

The Aarhus study was a retrospective evaluation of prospectively collected clinical FDG PET/CT data, approved by the local ethics committee of the Central Denmark Region (1-10-72-188-19). Inclusion into the dynamic whole-body (D-WB) protocol was solely based on whether patients were deemed fit to lie still for nearly 70 min while in the PET/CT scanner; in practice, this excluded patients with cognitive impairments.